Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Pathogens (Basel, Switzerland)|March 26, 2025
Extensive T-Cell Profiling Following SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTsHannah Solchenberger, Marcus Odendahl, Dirk Schriefer, et al.
Therapeutic Advances in Chronic Disease|May 1, 2019
Nonwalking response to fampridine in patients with multiple sclerosis in a real-world settingFrancisco Alejandro Rodriguez-Leal, Rocco Haase, Katja Akgün, et al.
Vaccines|March 28, 2024
Insights from Real-World Practice: The Dynamics of SARS-CoV-2 Infections and Vaccinations in a Large German Multiple Sclerosis CohortHernan Inojosa, Dirk Schriefer, Yassin Atta, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2017
Fampridine response in MS patients with gait impairment in a real-world setting: Need for new response criteria?Francisco Alejandro Rodriguez-Leal, Rocco Haase, Katja Thomas, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 30, 2023
Differential effects of selective versus unselective sphingosine 1-phosphate receptor modulators on T- and B-cell response to SARS-CoV-2 vaccinationUndine Proschmann, Magdalena Mueller-Enz, Christina Woopen, et al.
The Lancet Regional Health. Europe|April 8, 2024
Consensus quality indicators for monitoring multiple sclerosisIsabel Voigt, Stefanie Fischer, Undine Proschmann, et al.
Therapeutic Advances in Neurological Disorders|February 6, 2023
Natalizumab in cerebrospinal fluid and breastmilk of patients with multiple sclerosisIlaria Callegari, Mika Schneider, Vera Aebischer, et al.
Pageof 3